コンテンツへスキップ
Merck

Seizures associated with ofloxacin therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (1995-12-01)
S M Traeger, M F Bonfiglio, J A Wilson, B R Martin, N A Nackes
要旨

We describe four patients who had seizures while receiving ofloxacin; no other causes were evident. Common factors among all patients included advanced age and use of a high-dose regimen. The renal insufficiency of three patients and the timing of the seizures implicate accumulation of ofloxacin as a contributing factor. Other potentially related factors included electrolyte abnormalities and prior neurological insult. Improved awareness of and further investigation into the neurotoxic effects of ofloxacin may enhance its safe use.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
オフロキサシン, fluoroquinolone antibiotic
USP
オフロキサシン, United States Pharmacopeia (USP) Reference Standard
Supelco
オフロキサシン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
オフロキサシン, VETRANAL®, analytical standard
オフロキサシン, European Pharmacopoeia (EP) Reference Standard